These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Low doses of estradiol partly inhibit release of GH in sheep without affecting basal levels. Hudmon A; Davenport G; Coleman ES; Sartin JL Domest Anim Endocrinol; 2009 Oct; 37(3):181-7. PubMed ID: 19616401 [TBL] [Abstract][Full Text] [Related]
7. [Growth hormone and prolactin metabolism in chronic renal failure with hemodialysis]. Okajima E; Motomiya Y; Hirao Y Nihon Rinsho; 1992 Jan; 50 Suppl():606-13. PubMed ID: 1349657 [No Abstract] [Full Text] [Related]
8. The discovery of growth hormone-releasing hormone: an update. Thorner MO J Neuroendocrinol; 2008 Jun; 20(6):653-4. PubMed ID: 18601685 [No Abstract] [Full Text] [Related]
9. [Study on the secretion of the somatotropic hormone during the 1st month of life]. Massi-Benedetti F; Gallo G; Barboni G; Falorni A Minerva Pediatr; 1976 May; 28(18):1136-8. PubMed ID: 796652 [No Abstract] [Full Text] [Related]
10. Pulsatile growth hormone secretory pattern: autofeedback regulation and effects on growth factors. Jansson JO; Carlsson L; Ekberg S; Isgaard J; Carlsson B; Billig H; Leroith D; Roberts CT; Adamo M; Woloschak M Acta Paediatr Scand Suppl; 1990; 367():98-102. PubMed ID: 1977279 [No Abstract] [Full Text] [Related]
11. [Regulation of growth hormone secretion]. Furlanetto TW; Rosenthal D AMB Rev Assoc Med Bras; 1980 Apr; 26(4):146-8. PubMed ID: 6107962 [No Abstract] [Full Text] [Related]
12. [Secretion of HGH in the feto-neonatal period]. Reitano G Minerva Pediatr; 1976 May; 28(18):1105-11. PubMed ID: 796651 [No Abstract] [Full Text] [Related]
13. [Corticosteroids and secretion of somatotropin. Preliminary study]. Bottone E; Macchia PA; Saggese G; Materazzi F Minerva Pediatr; 1976 May; 28(18):1112-5. PubMed ID: 189172 [No Abstract] [Full Text] [Related]
14. Effects of a high-glucose environment on the pituitary growth hormone-releasing hormone receptor: type 1 diabetes compared with in vitro glucotoxicity. Bédard K; Strecko J; Thériault K; Bédard J; Veyrat-Durebex C; Gaudreau P Am J Physiol Endocrinol Metab; 2008 Apr; 294(4):E740-51. PubMed ID: 18285528 [TBL] [Abstract][Full Text] [Related]
15. Growth hormone excess and the effect of octreotide in cats with diabetes mellitus. Slingerland LI; Voorhout G; Rijnberk A; Kooistra HS Domest Anim Endocrinol; 2008 Nov; 35(4):352-61. PubMed ID: 18801640 [TBL] [Abstract][Full Text] [Related]
16. An inhibition of the hypothalamic somatostatinergic tone is not the cause of the enhanced growth hormone response to growth hormone-releasing hormone in patients with liver cirrhosis. Fanciulli G; Tomasi PA; Giusti M; Bertoncelli A; Deplano A; Garrucciu G; Delitala G Exp Clin Endocrinol Diabetes; 2008 Mar; 116(3):148-51. PubMed ID: 18095239 [TBL] [Abstract][Full Text] [Related]
17. Understanding the multifactorial control of growth hormone release by somatotropes: lessons from comparative endocrinology. Gahete MD; Durán-Prado M; Luque RM; Martínez-Fuentes AJ; Quintero A; Gutiérrez-Pascual E; Córdoba-Chacón J; Malagón MM; Gracia-Navarro F; Castaño JP Ann N Y Acad Sci; 2009 Apr; 1163():137-53. PubMed ID: 19456335 [TBL] [Abstract][Full Text] [Related]
18. Increased GH secretion in scrapie, a prion-associated neurodegenerative disease, is not due to suppressed IGF-1 negative feedback. Viguié C; Picard-Hagen N; Gayrard V; Toutain PL Domest Anim Endocrinol; 2009 Apr; 36(3):127-37. PubMed ID: 19179038 [TBL] [Abstract][Full Text] [Related]